As many as 3 million Americans live with T1D. Each year more than 15,000 children and 15,000 adults are diagnosed with the disease. More than 500,000 people from corporations, schools, and families across the country participate in the JDRF Walk to Cure Diabetes, a family-friendly event to raise critical funds for diabetes research. Last year, the Walks raised $86 million to fund research for diabetes and its complications.
About Lance® Sandwich CrackersLance® Sandwich Crackers and Lance® Cracker Creations® are available in more than two dozen varieties, including ToastChee, Whole Grain and the new Cracker Creations® Granola and 5 Grain varieties. Each product is made with freshly-baked, crispy crackers or granola wafers and real peanut butter, cheese, cream cheese or chocolate filling. Lance® Sandwich Crackers and Lance® Cracker Creations® have 0 grams trans fat, no preservatives and no high fructose corn syrup.
About Snyder's-Lance, Inc. Snyder's-Lance, Inc., (Nasdaq-GS: LNCE) headquartered in Charlotte, NC, manufactures and markets snack foods throughout the United States and internationally. The Company's products include pretzels, sandwich crackers, potato chips, cookies, tortilla chips, restaurant style crackers, nuts and other snacks. Snyder's-Lance has manufacturing facilities in North Carolina, Pennsylvania, Iowa, Indiana, Georgia, Arizona, Massachusetts, Florida, Ohio, and Ontario, Canada. Products are sold under the Snyder's of Hanover, Lance, Krunchers!, Cape Cod, EatSmart Naturals, Jays, Grande, Tom's, Archway, O-Ke-Doke and Stella D'oro brand names along with a number of private label and third party brands. Products are distributed widely through grocery and mass merchandisers, convenience stores, club stores, food service outlets and other channels. LNCE-GAbout JDRFJDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal. Since its founding in 1970, JDRF has awarded more than $1.6 billion to diabetes research. Past JDRF efforts have helped to significantly advance the care of people with this disease and have expanded the critical scientific understanding of T1D. JDRF will not rest until T1D is fully conquered. More than 80 percent of JDRF's expenditures directly support research and research-related education. SOURCE Snyder's-Lance, Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts